• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于原料药和药物剂型中托哌酮杂质测定的精确单HPLC方法的开发与验证。

Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms.

作者信息

Raju Thummala Veera Raghava, Seshadri Raja Kumar, Arutla Srinivas, Mohan Tharlapu Satya Sankarsana Jagan, Rao Ivaturi Mrutyunjaya, Nittala Someswara Rao

机构信息

Analytical Research and Development, Integrated Product Development, Dr. Reddy's Laboratories Ltd., Bachupally, Hyderabad-500072, India.

出版信息

Sci Pharm. 2013 Jan-Mar;81(1):123-38. doi: 10.3797/scipharm.1209-17. Epub 2012 Nov 5.

DOI:10.3797/scipharm.1209-17
PMID:23641333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3617673/
Abstract

A novel, sensitive, stability-indicating HPLC method has been developed for the quantitative estimation of Tolperisone-related impurities in both bulk drugs and pharmaceutical dosage forms. Effective chromatographic separation was achieved on a C18 stationary phase with a simple mobile phase combination delivered in a simple gradient programme, and quantitation was by ultraviolet detection at 254 nm. The mobile phase consisted of a buffer and acetonitrile delivered at a flow rate 1.0 ml/min. The buffer consisted of 0.01 M potassium dihydrogen phosphate with the pH adjusted to 8.0 by using diethylamine. In the developed HPLC method, the resolution between Tolperisone and its four potential impurities was found to be greater than 2.0. Regression analysis showed an R value (correlation coefficient) of greater than 0.999 for the Tolperisone impurities. This method was capable of detecting all four impurities of Tolperisone at a level of 0.19 μg/mL with respect to the test concentration of 1000 μg/mL for a 10 µl injection volume. The tablets were subjected to the stress conditions of hydrolysis, oxidation, photolysis, and thermal degradation. Considerable degradation was found to occur in base hydrolysis, water hydrolysis, and oxidation. The stress samples were assayed against a qualified reference standard and the mass balance was found to be close to 100%. The established method was validated and found to be linear, accurate, precise, specific, robust, and rugged.

摘要

已开发出一种新颖、灵敏、指示稳定性的高效液相色谱法,用于定量测定原料药和药物制剂中托哌酮相关杂质。在C18固定相上,通过简单的流动相组合并采用简单的梯度程序实现了有效的色谱分离,定量检测采用254nm紫外检测。流动相由一种缓冲液和乙腈组成,流速为1.0ml/min。缓冲液由0.01M磷酸二氢钾组成,用二乙胺将pH调至8.0。在所开发的高效液相色谱法中,托哌酮与其四种潜在杂质之间的分离度大于2.0。回归分析表明,托哌酮杂质的R值(相关系数)大于0.999。对于10µl进样体积、1000µg/mL的测试浓度,该方法能够检测到所有四种托哌酮杂质,检测限为0.19µg/mL。对片剂进行了水解、氧化、光解和热降解等强制降解试验。发现碱水解、水水解和氧化过程中发生了显著降解。对强制降解样品与合格的参比标准品进行测定,质量平衡接近100%。所建立的方法经过验证,具有线性、准确性、精密度、特异性、稳健性和耐用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/772b8242312d/scipharm-2013-81-123f6d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/ee33c31d246b/scipharm-2013-81-123f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/bbc878ac9448/scipharm-2013-81-123f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/861d2c01cd8d/scipharm-2013-81-123f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/e1f496fe7ae8/scipharm-2013-81-123f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/e355376e88e4/scipharm-2013-81-123f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/5b39b52dc15e/scipharm-2013-81-123f5b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/d44b03b18bdd/scipharm-2013-81-123f5c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/75969ead8fb8/scipharm-2013-81-123f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/543073cbe911/scipharm-2013-81-123f6b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/891b8a9aabd3/scipharm-2013-81-123f6c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/772b8242312d/scipharm-2013-81-123f6d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/ee33c31d246b/scipharm-2013-81-123f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/bbc878ac9448/scipharm-2013-81-123f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/861d2c01cd8d/scipharm-2013-81-123f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/e1f496fe7ae8/scipharm-2013-81-123f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/e355376e88e4/scipharm-2013-81-123f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/5b39b52dc15e/scipharm-2013-81-123f5b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/d44b03b18bdd/scipharm-2013-81-123f5c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/75969ead8fb8/scipharm-2013-81-123f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/543073cbe911/scipharm-2013-81-123f6b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/891b8a9aabd3/scipharm-2013-81-123f6c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/3617673/772b8242312d/scipharm-2013-81-123f6d.jpg

相似文献

1
Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms.用于原料药和药物剂型中托哌酮杂质测定的精确单HPLC方法的开发与验证。
Sci Pharm. 2013 Jan-Mar;81(1):123-38. doi: 10.3797/scipharm.1209-17. Epub 2012 Nov 5.
2
A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets.一种经过验证的用于测定伏立康唑片中降解杂质和非对映异构体的稳定性指示液相色谱法。
Sci Pharm. 2012 Oct-Dec;80(4):879-88. doi: 10.3797/scipharm.1204-24. Epub 2012 Jun 18.
3
Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Drotaverine Impurities in API and Pharmaceutical Formulation.用于原料药和药物制剂中屈他维林杂质测定的稳定性指示反相高效液相色谱法的开发与验证
Sci Pharm. 2013 Oct 21;82(1):99-115. doi: 10.3797/scipharm.1309-06. Print 2014 Jan-Mar.
4
Degradation Pathway for Eplerenone by Validated Stability Indicating UP-LC Method.依普利酮降解途径的验证性稳定性指示超高效液相色谱法
ISRN Pharm. 2012;2012:251247. doi: 10.5402/2012/251247. Epub 2012 Oct 14.
5
A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.建立了左氧氟沙星在降解产物、其工艺相关杂质及氧化降解产物存在下的稳定性指示反相高效液相色谱检测方法。
J Pharm Biomed Anal. 2009 Dec 5;50(5):710-7. doi: 10.1016/j.jpba.2009.05.038. Epub 2009 Jun 6.
6
QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form.基于质量源于设计(QbD)理念开发用于同时定量片剂剂型中替米沙坦和氢氯噻嗪杂质的高效液相色谱(HPLC)方法。
Pract Lab Med. 2020 Jun 1;21:e00169. doi: 10.1016/j.plabm.2020.e00169. eCollection 2020 Aug.
7
A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.在药物制剂中存在降解产物和其工艺相关杂质的情况下,对双嘧达莫进行稳定性指示的反相高效液相色谱法的验证。
Biomed Chromatogr. 2022 Jan;36(1):e5247. doi: 10.1002/bmc.5247. Epub 2021 Oct 21.
8
Stress Degradation Behavior of Atorvastatin Calcium and Development of a Suitable Stability-Indicating LC Method for the Determination of Atorvastatin, its Related Impurities, and its Degradation Products.阿托伐他汀钙的应力降解行为及一种适用于测定阿托伐他汀、其相关杂质及其降解产物的稳定性指示液相色谱法的开发。
Sci Pharm. 2013 Jan-Mar;81(1):93-114. doi: 10.3797/scipharm.1208-06. Epub 2012 Oct 9.
9
A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.建立测定埃索美拉唑镁肠溶片有关物质的超高效液相色谱法。
J Pharm Biomed Anal. 2012 Jan 5;57:109-14. doi: 10.1016/j.jpba.2011.08.025. Epub 2011 Aug 22.
10
A stability indicating LC method for zolmitriptan.一种用于佐米曲普坦的稳定性指示液相色谱法。
J Pharm Biomed Anal. 2005 Sep 15;39(3-4):503-9. doi: 10.1016/j.jpba.2005.04.018.

本文引用的文献

1
Raynaud's phenomenon.雷诺现象
Joint Bone Spine. 2007 Jan;74(1):e1-8. doi: 10.1016/j.jbspin.2006.07.002. Epub 2006 Dec 4.
2
HPLC determination of tolperisone in human plasma.高效液相色谱法测定人血浆中托哌酮的含量。
Arch Pharm Res. 2006 Apr;29(4):339-42. doi: 10.1007/BF02968581.
3
A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms.托哌酮对七种不同电压依赖性钠通道亚型作用的比较研究。
Eur J Pharmacol. 2006 May 24;538(1-3):5-14. doi: 10.1016/j.ejphar.2006.03.034. Epub 2006 Mar 21.
4
Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.托哌酮类药物通过阻断电压门控钠通道和钙通道来抑制脊髓反射。
J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. doi: 10.1124/jpet.105.089805. Epub 2005 Aug 26.
5
Simultaneous determination of tolperisone and lidocaine by high performance liquid chromatography.高效液相色谱法同时测定托哌酮和利多卡因
J Pharm Biomed Anal. 2001 Dec;26(5-6):865-72. doi: 10.1016/s0731-7085(01)00462-9.
6
High performance thin layer chromatographic determination of tolperisone hydrochloride.高效薄层色谱法测定盐酸托哌酮
J Pharm Biomed Anal. 1999 Jun;20(1-2):401-4. doi: 10.1016/s0731-7085(99)00023-0.